Abstract:
:In this study, alterations in gene expression patterns have been examined in v-Rel-transformed avian bone marrow cells. Using a conditional v-Rel estrogen receptor chimera (v-RelER) which transforms cells in an estrogen-dependent manner, we constructed subtraction cDNA libraries from v-RelER-transformed bone marrow cells. Several different sequences were identified whose expression was altered upon hormone activation of v-RelER. These include two genes related to the MIP-1 chemokine family (mip-1beta and a tca3 homologue), a cell surface antigen sca-2 and the transcription factor nfkb1. The expression of each gene was assayed in a number of wild-type and mutant v-Rel-expressing fibroblast and hematopoietic cells. All v-Rel-transformed hematopoietic cells tested express high levels of nfkb1 and sca-2. In fibroblasts, wild-type v-Rel induced expression of mip-1beta and nfkb1, while nontransforming mutants of v-Rel failed to do so, suggesting a role for these two genes in v-Rel mediated transformation. Finally, these genes are expressed at high levels in cells overexpressing wild-type and truncated forms of c-Rel, implying that v-Rel transforms, in part, by induction of c-Rel target genes.
journal_name
Oncogenejournal_title
Oncogeneauthors
Petrenko O,Ischenko I,Enrietto PJdoi
10.1038/sj.onc.1201334subject
Has Abstractpub_date
1997-10-02 00:00:00pages
1671-80issue
14eissn
0950-9232issn
1476-5594journal_volume
15pub_type
杂志文章相关文献
ONCOGENE文献大全abstract::We isolated three related cDNA clones from a mouse cerebellar library; the type I cDNA was identical to the gene encoding the apoptosis-associated tyrosine kinase (AATYK), whose expression in myeloid precursor cells is increased during growth arrest or apoptosis. Low levels of AATYK mRNA expression were seen in adult ...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1204210
更新日期:2001-03-01 00:00:00
abstract::BALB/c mice heterozygous for Trp53 develop a high proportion of spontaneous mammary tumors, a phenotype distinct from other mouse strains. BALB/c-Trp53+/- female mice, thus, resemble the hereditary Li-Fraumeni syndrome (LFS) characterized by early-onset of breast cancer, even though LFS involves TP53 mutations, which ...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2013.38
更新日期:2013-11-28 00:00:00
abstract::The Notch ligand delta-like ligand 4 (DLL4) is an essential component expressed by endothelial tip cells during angiogenic sprouting. We have described a conceptually novel therapeutic strategy for targeting tumor angiogenesis and endothelial tip cells based on DNA vaccination against DLL4. Immunization with DLL4-enco...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2010.176
更新日期:2010-07-29 00:00:00
abstract::The phosphatase Cdc25A was shown to be a target of the transcription factor c-Myc. Myc-induced apoptosis appeared dependent on Cdc25A expression and Cdc25A over-expression could substitute for Myc-triggered apoptosis. These findings suggested that an important downstream component of Myc-mediated apoptosis was identif...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1204499
更新日期:2001-07-27 00:00:00
abstract::The c-myc proto-oncogene has been shown to cause blockages to differentiation in many cell lineages. Although the mechanism by which c-Myc affects this process remains unknown, it is considered that it might result indirectly as an outcome of the continued cell-cycle progression invoked by c-Myc in cells which must gr...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1201124
更新日期:1997-06-12 00:00:00
abstract::A lot of effort has been done to study how cancer cells react to low-oxygen tension, a condition known as hypoxia. Indeed, abnormal and dysfunctional blood vessels in the tumor are incapable to restore oxygenation, therefore perpetuating hypoxia, which, in turn, will fuel tumor progression, metastasis and resistance t...
journal_title:Oncogene
pub_type: 杂志文章,评审
doi:10.1038/onc.2013.121
更新日期:2014-04-03 00:00:00
abstract::MOZ and MLL, encoding a histone acetyltransferase (HAT) and a histone methyltransferase, respectively, are targets for recurrent chromosomal translocations found in acute myeloblastic or lymphoblastic leukemia. In MOZ (MOnocytic leukemia Zinc-finger protein)/CBP- or mixed lineage leukemia (MLL)-rearranged leukemias, a...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2010.254
更新日期:2010-09-09 00:00:00
abstract::The nucleolus is one of the functional nuclear compartments in which the ribosome biogenesis takes place. Proteomic analysis revealed a large number of nucleolar proteins that are involved in diverse cellular processes, including biogenesis of ribonucleoprotein particles, stress responses, cell proliferation and cell ...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2009.473
更新日期:2010-03-25 00:00:00
abstract::P53 is a tumor suppressor gene that plays a crucial role in suppressing tumorigenesis by inducing either cell cycle arrest or apoptosis in cells with DNA damage. In more than 50% of tumors p53 is inactivated by gene mutations. However, there have also been reports of tumor cells in which p53 remains wild type and is p...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1210110
更新日期:2007-05-10 00:00:00
abstract::Early growth response-1 (Egr-1) is overexpressed in human prostate tumors and contributes to cancer progression. On the other hand, mutation of p53 is associated with advanced prostate cancer, as well as with metastasis and hormone independence. This study shows that in prostate cell lines in culture, Egr-1 overexpres...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2010.24
更新日期:2010-05-06 00:00:00
abstract::The primary tumors from 15 untreated patients with Burkitt's lymphoma were analysed for abnormalities in the coding region of the MYC gene by single stranded conformational polymorphism (SSCP) analysis followed by DNA sequencing. Fourteen of the 15 tumors had one or more clonal mutations. Forty one mutations were foun...
journal_title:Oncogene
pub_type: 杂志文章
doi:
更新日期:1993-10-01 00:00:00
abstract::We have developed a new yeast-based assay for the detection of PTEN nonsense mutation, and applied it to a total of 42 astrocytic tumors. The assay utilizes homologous recombination of PCR-amplified PTEN cDNA samples to a yeast vector which expresses an in-frame PTEN::ADE2 chimera protein. An allele of nonsense mutati...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1203795
更新日期:2000-09-07 00:00:00
abstract::The ability of glioma cells to migrate great distances from a primary tumor mass is the primary cause of tumor recurrence. The urokinase-type plasminogen activator (uPA) is a serine protease that can initiate proteolytic cascades, which result in remodeling of extracellular matrix and basement membrane, allowing cells...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1206164
更新日期:2003-01-23 00:00:00
abstract::Protein phosphatase inhibitors are often considered as tumor promoters. Protein phosphatase 1 regulatory subunit 1A (PPP1R1A) is a potent protein phosphatase 1 (PP1) inhibitor; however, its role in tumor development is largely undefined. Here we characterize, for the first time, the functions of PPP1R1A in Ewing sarco...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2017.378
更新日期:2018-02-08 00:00:00
abstract::The Cancer Genome Atlas consortium brought us terabytes of information about genetic alterations in different types of human tumors. While many cancer-driver genes have been identified through these efforts, interrogating cancer genomes has also shed new light on tumor complexity. Mutations were found to vary tremendo...
journal_title:Oncogene
pub_type: 杂志文章,评审
doi:10.1038/s41388-019-1127-5
更新日期:2020-03-01 00:00:00
abstract::Galectin-3 is a multifunctional carbohydrate-binding protein found in the nucleus, cytoplasm and the extracellular milieu. Nuclear galectin-3 expression is associated with cell proliferation, and its role in pre-mRNA splicing has been suggested. In this report, we investigated the role of galectin-3 on cyclin D(1) gen...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1205820
更新日期:2002-11-14 00:00:00
abstract::Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and incurable disease. Poor prognosis is due to multiple reasons, including acquisition of resistance to gemcitabine, the first-line chemotherapeutic approach. Thus, there is a strong need for novel therapies, targeting more directly the molecular aberrations of...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2015.270
更新日期:2016-04-21 00:00:00
abstract::The introduction of new therapies against particular genetic mutations in non-small-cell lung cancer is a promising avenue for improving patient survival, but the target population is small. There is a need to discover new potential actionable genetic lesions, to which end, non-conventional cancer pathways, such as RN...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2015.469
更新日期:2016-08-18 00:00:00
abstract::Many components of the Wnt/β-catenin signaling pathway have critical functions in mammary gland development and tumor formation, yet the contribution of glycogen synthase kinase-3 (GSK-3α and GSK-3β) to mammopoiesis and oncogenesis is unclear. Here, we report that WAP-Cre-mediated deletion of GSK-3 in the mammary epit...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2014.279
更新日期:2015-07-01 00:00:00
abstract::We recently reported an interaction between the p14(ARF) protein and human topoisomerase I (Topo I) resulting in the stimulation of the relaxation activity of Topo I. Our data showed that the complex between the two proteins was located within the nucleolus. In the present work, we have investigated the regions of p14...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1206214
更新日期:2003-04-03 00:00:00
abstract::Mutation induction in directly exposed cells is currently regarded as the main component of the genetic risk of ionizing radiation for humans. However, recent data on the transgenerational increases in mutation rates in the offspring of irradiated parents indicate that the genetic risk could be greater than predicted ...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1209723
更新日期:2006-11-30 00:00:00
abstract::DNA methylation alterations are now widely recognized as a contributing factor in human tumorigenesis. A significant number of tumor suppressor genes are transcriptionally silenced by promoter hypermethylation, and recent research implicates alterations in chromatin structure as the mechanistic basis for this repressi...
journal_title:Oncogene
pub_type: 杂志文章,评审
doi:10.1038/sj.onc.1205602
更新日期:2002-08-12 00:00:00
abstract::LIM-kinase 2 (LIMK2) belongs to the LIMK family of proteins, which comprises LIMK1 and LIMK2. Both proteins regulate actin polymerization through phosphorylation and inactivation of the actin depolymerizing factor cofilin. In this study, we show that the level of LIMK2 protein is increased in neuroblastoma, BE(2)-C ce...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2009.367
更新日期:2010-01-28 00:00:00
abstract::The proto-oncogene BMI1 and its product, Bmi1, is overexpressed in various types of tumors, particularly in aggressive tumors and tumors resistant to conventional chemotherapy. BMI1/Bmi1 is also crucially involved in cancer-initiating cell maintenance, and is recurrently upregulated in mantle cell lymphoma (MCL), espe...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2013.177
更新日期:2014-04-24 00:00:00
abstract::Cancer cells harboring oncogenic BRaf mutants, but not oncogenic KRas mutants, are sensitive to MEK inhibitors (MEKi). The mechanism underlying the intrinsic resistance to MEKi in KRas-mutant cells is under intensive investigation. Here, we pursued this mechanism by live imaging of extracellular signal-regulated kinas...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2015.16
更新日期:2015-11-05 00:00:00
abstract::Kaposi's sarcoma (KS)-associated herpesvirus (KSHV), a gamma-2 herpesvirus, is the causative agent of KS, primary effusion lymphoma (PEL), and a plasma cell variant of multicentric Castleman's disease. Although KSHV latency is detected in KS-related tumors, oncogenic pathways activated by KSHV latent infection are not...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/s41388-019-0726-5
更新日期:2019-05-01 00:00:00
abstract::Tumor necrosis factor-related apoptosis-inducing ligand-receptor 1 (TRAIL-R1) and tumor necrosis factor-related apoptosis-inducing ligand-receptor 2 (TRAIL-R2) are cell-surface receptors involved in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell-death signaling. TRAIL-R1 and TRAIL-R2 gene...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1204103
更新日期:2001-01-18 00:00:00
abstract::B7-H4, a member of B7 family, is a transmembrane protein and inhibits T-cells immunity. However, in a variety of tumor cells, B7-H4 was detected predominantly in intracellular compartments with unknown mechanism and functions. In this study, we analyzed B7-H4 expression and subcellular distribution by immunohistochemi...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2012.600
更新日期:2013-11-14 00:00:00
abstract::Genetic analysis of beta-catenin-induced oncogenic transformation in chicken embryo fibroblasts (CEF) revealed the following prerequisites for oncogenicity: (1) removal of the N terminal phosphorylation sites targeted by glycogen synthase kinase 3beta (GSK3beta), (2) retention of the N terminal transactivation domain,...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1205796
更新日期:2002-10-10 00:00:00
abstract::Upregulation and activation of epidermal growth factor receptor and/or urokinase-type plasminogen activator receptor in a variety of cancers have been shown to be associated with poor prognosis. High-molecular-weight kininogen can be hydrolysed by plasma kallikrein to bradykinin and cleaved high-molecular-weight kinin...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2009.132
更新日期:2009-07-30 00:00:00